RxDoctor Payments Data

Utpal Pandya, MD

Cardiovascular Disease · Atlanta, GANPI 1649254848

Payments from drug & device makers

What this record shows

This record is dominated by other: $220,392 of the $220,718 with a category attached, or 99.9%. Edwards Lifesciences accounts for 99.9% of it on its own, with 2 other manufacturers making up the rest. 2025 is the largest year on record at $220,392, more than ten times the $130 reported in 2019. Among cardiovascular disease clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$220,718in general payments, 2019–2025

Across 7 payments — averaging $31,531 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$220K
  • Shockwave Medical, Inc$183
  • Medtronic$143

What the payments were for

  • Food & beverage$3260%
  • Other$220,392100%

General payments by program year

19
20
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Edwards Lifesciences3$220,392
Shockwave Medical, Inc2$183
Medtronic2$143

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$220,718 in reported general payments places this provider in the 95th percentile of 640 cardiovascular disease providers in Georgia.

See all cardiovascular disease providers in Georgia

Medicare billing

Part B allowed, 2024
$9,133
Medicare patients
64
Services billed
109

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban37$35,664
PradaxaDabigatran Etexilate Mesylate63$18,057
ClopidogrelClopidogrel Bisulfate57$977
Isosorbide Mononitrate ErIsosorbide Mononitrate83$934
Atorvastatin Calcium73$814
Prasugrel Hcl23$631
Nitroglycerin24$603
Rosuvastatin Calcium52$557
Ranolazine ErRanolazine12$532
Metoprolol Succinate35$480
Lisinopril38$427
Losartan Potassium31$359
Amlodipine Besylate24$276
Metoprolol Tartrate32$268
Carvedilol19$200

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →